[1]
Rothstein DM, Rifamycins, Alone and in Combination. Cold Spring Harbor perspectives in medicine. 2016 Jul 1 [PubMed PMID: 27270559]
[2]
Howard P,Twycross R,Grove G,Charlesworth S,Mihalyo M,Wilcock A, Rifampin (INN Rifampicin). Journal of pain and symptom management. 2015 Dec [PubMed PMID: 26432572]
[3]
Mieras LF,Taal AT,van Brakel WH,Cambau E,Saunderson PR,Smith WCS,Prakoeswa CRS,Astari L,Scollard DM,do Nascimento DC,Grosset J,Kar HK,Izumi S,Gillini L,Virmond MCL,Sturkenboom MGG, An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP+. BMC infectious diseases. 2018 Oct 5 [PubMed PMID: 30290790]
[4]
Sotgiu G,Centis R,D'ambrosio L,Migliori GB, Tuberculosis treatment and drug regimens. Cold Spring Harbor perspectives in medicine. 2015 Jan 8 [PubMed PMID: 25573773]
[5]
Seid MA,Ayalew MB,Muche EA,Gebreyohannes EA,Abegaz TM, Drug-susceptible tuberculosis treatment success and associated factors in Ethiopia from 2005 to 2017: a systematic review and meta-analysis. BMJ open. 2018 Sep 25 [PubMed PMID: 30257846]
[6]
Campbell EA,Korzheva N,Mustaev A,Murakami K,Nair S,Goldfarb A,Darst SA, Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell. 2001 Mar 23; [PubMed PMID: 11290327]
[7]
McClure WR,Cech CL, On the mechanism of rifampicin inhibition of RNA synthesis. The Journal of biological chemistry. 1978 Dec 25; [PubMed PMID: 363713]
[8]
Wietholtz H,Marschall HU,Sjövall J,Matern S, Stimulation of bile acid 6 alpha-hydroxylation by rifampin. Journal of hepatology. 1996 Jun [PubMed PMID: 8835747]
[10]
Treatment of tuberculosis. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2003 Jun 20; [PubMed PMID: 12836625]
[12]
Tran JH,Montakantikul P, The safety of antituberculosis medications during breastfeeding. Journal of human lactation : official journal of International Lactation Consultant Association. 1998 Dec [PubMed PMID: 10205455]
[13]
Smith SJ,Lee AJ,Maddix DS,Chow AW, Pill-induced esophagitis caused by oral rifampin. The Annals of pharmacotherapy. 1999 Jan [PubMed PMID: 9972381]
[14]
Chen J,Raymond K, Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor. Annals of clinical microbiology and antimicrobials. 2006 Feb 15; [PubMed PMID: 16480505]
[16]
Yim SY,Koo JS,Kim YJ,Park SJ,Kim JN,Jung SW,Yim HJ,Lee SW,Choi JH,Kim CD, Rifampin-induced Pseudomembranous Colitis with Rectosigmoid Sparing. Clinical endoscopy. 2011 Dec [PubMed PMID: 22741126]
[18]
Prince MI,Burt AD,Jones DE, Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis. Gut. 2002 Mar [PubMed PMID: 11839728]
[19]
Khurana S,Singh P, Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials. Liver international : official journal of the International Association for the Study of the Liver. 2006 Oct [PubMed PMID: 16953834]
[21]
Niemi M,Backman JT,Fromm MF,Neuvonen PJ,Kivistö KT, Pharmacokinetic interactions with rifampicin : clinical relevance. Clinical pharmacokinetics. 2003 [PubMed PMID: 12882588]
[22]
Saukkonen JJ,Cohn DL,Jasmer RM,Schenker S,Jereb JA,Nolan CM,Peloquin CA,Gordin FM,Nunes D,Strader DB,Bernardo J,Venkataramanan R,Sterling TR, An official ATS statement: hepatotoxicity of antituberculosis therapy. American journal of respiratory and critical care medicine. 2006 Oct 15 [PubMed PMID: 17021358]
[23]
Chawla PK,Udwadia ZF,Soman R,Mahashur AA,Amale RA,Dherai AJ,Lokhande RV,Naik PR,Ashavaid TF, Importance of Therapeutic Drug Monitoring of Rifampicin. The Journal of the Association of Physicians of India. 2016 Aug; [PubMed PMID: 27762112]
[24]
Sridhar A,Sandeep Y,Krishnakishore C,Sriramnaveen P,Manjusha Y,Sivakumar V, Fatal poisoning by isoniazid and rifampicin. Indian journal of nephrology. 2012 Sep [PubMed PMID: 23326053]
[25]
Girling DJ,Hitze KL, Adverse reactions to rifampicin. Bulletin of the World Health Organization. 1979 [PubMed PMID: 311712]